| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2561804 | Pharmacological Research | 2007 | 8 Pages |
Recent findings regarding basic, pre-clinical and clinical studies on a mango stem bark extract (MSBE) developed in Cuba (Vimang) on an industrial scale are summarized. Ethnomedical studies, extract reproducibility, biological effects and clinical evaluations in terms of patient quality of life are described as experimental evidences to support the statement that natural products, even being a mixture of compounds, could be as effective as “monoceuticals” for medical uses. Discussion about the use of “monoceuticals” versus “natureceuticals” in health care and medicine is based on effectiveness and availability, taking Vimang as an example of a natural product with supported scientific evidence to be used as antioxidant, analgesic, anti-inflammatory and immunomodulator.
